Breaking News on Global Pharmaceutical Technology & Manufacturing

Top Headlines

Sanofi aims to sell Allegra plant ahead of 2016 shutdown

Sanofi has confirmed it wants to sell the Kansas City facility at which it makes the allergy drug Allegra (Fexofenadine).

Pfizer to pay for clean up

Chemical synthesis of IL-10 cytokine 90% cheaper than bioproduction, Provepep

Chemical synthesis of peptides and proteins can be done at a tenth of the cost of bioproduction says French chemistry specialist Provepep.

US FTC: 'Product-hopping' illegally impedes generic entry

The US Government is becoming increasingly critical of industry attempts to ward off competition through ‘product-hopping,’ an IP lawyer says.

Latest job cuts leave MannKind a third smaller than in 2014, says CFO

MannKind has cut more jobs in efforts to streamline operations, leaving the inhalable insulin manufacturer around a third smaller than this time last year.

Conventional wisdom yields conventional outcomes, says 'Brilliant' drug delivery professor

In an exclusive Q&A, nanoparticle pioneer Kathryn Whitehead wishes industry would invest more in delivery vehicles and predicts Alnylam will be first to commercialise an siRNA therapeutic.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...